DHX15 inhibits mouse APOBEC3 deamination

Wenming Zhao1, Ayan Modak1, Susan R Ross1

  • 1Department of Microbiology and Immunology, University of Illinois Chicago College of Medicine, Chicago, Illinois, United States of America.

Plos Pathogens
|April 1, 2025
PubMed

Insights

Mouse APOBEC3 (A3) protein

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • APOBEC3 proteins are crucial for innate immunity against viral infections.
  • Human APOBEC3 inactivates HIV-1 via cytidine deamination, but mouse APOBEC3 (mA3) does not effectively target murine retroviruses.
  • The mechanism behind mA3's limited antiviral activity remains unclear.

Purpose of the Study:

  • To investigate the interaction partners of mA3.
  • To elucidate the mechanism by which mA3's antiviral activity is regulated.
  • To understand the role of mA3 in host defense against murine retroviruses.

Main Methods:

  • Co-immunoprecipitation assays to identify mA3 interacting proteins.
  • In vitro cytidine deaminase activity assays.
  • Murine leukemia virus (MLV) replication assays.
  • Western blotting and quantitative PCR for gene knockdown analysis.
  • Analysis of proviral DNA mutations and cellular DNA damage.

Main Results:

  • The dead box helicase DHX15 was identified as an interactor of mA3, inhibiting its deamination activity.
  • DHX15 is incorporated into MLV virions independently of mA3.
  • Knockdown of DHX15 enhanced MLV replication and increased G-to-A mutations in proviral DNA.
  • DHX15 knockdown led to DNA damage in murine cells.

Conclusions:

  • DHX15 negatively regulates mA3's antiviral cytidine deaminase activity.
  • DHX15 plays a role in MLV replication and potentially in maintaining genome integrity in cells expressing mA3.
  • Understanding the DHX15-mA3 interaction provides insights into host-pathogen interactions and retroviral restriction mechanisms.